Intuitive Surgical (NASDAQ:) posted first-quarter earnings and revenue that beat analyst expectations on Thursday.
The company’s shares fell slightly by 0.3% in after-hours trading.
The medical device maker reported Q1 earnings per share (EPS) of $1.50, surpassing the consensus projection of $1.42.
Revenue came in at $1.89 billion, exceeding the consensus forecast of $1.87 billion.
Worldwide procedure growth was reported at 16%, compared to 26% year-over-year and above the estimated growth of 14.2%.
“The core measures of our business remained healthy this quarter, as we reached meaningful milestones across several parts of our business,” said Gary Guthart, Intuitive CEO.
“We are pleased by feedback from our measured da Vinci 5 launch as well as the continued adoption of SP and Ion, and we remain focused on delivering the goals we share with our customers, including improving patient outcomes.”